European Journal of Dermatology
MENUSevere acneiform skin reaction during therapy with erlotinib (Tarceva ®), an epidermal growth factor receptor (EGFR) inhibitor Volume 17, issue 6, November-December 2007
Authors
Department of Dermatology, University of Regensburg, 93042 Regensburg, Germany
- DOI : 10.1684/ejd.2007.0286
- Page(s) : 552-3
- Published in: 2007
To access the full article text, click here.